The use of hematopoietic cell transplantation has expanded and evolved substantially in the
last decade. New stem cell sources and stem cell mobilizing agents have been introduced in …

Hematopoietic stem-cell transplantation, which is used to treat both malignant and
nonmalignant conditions, was first conceived more than 50 years ago, but problems …

Hematopoietic stem cell transplantation is a highly specialized and unique medical
procedure. Autologous transplantation allows the administration of high-dose chemotherapy …

Hematopoietic cell transplantation has developed from a treatment of “last resort” to an
effective therapy for patients with a variety of hematologic diseases. Developments in this …

Allogeneic bone marrow or blood stem cell transplantation (SCT) has changed its face in the
last two decades. The introduction of nonmyeloablative conditioning regimens has reduced …

HEMATOPOIETIC STEM CELL TRANSPLANTATION has been used for many years to treat
various malignant and nonmalignant hematologic conditions. However, the high-dose …

Bone marrow transplantation has evolved significantly over the past 40 years. The initial
rationale of using donor bone marrow to guarantee a supply of hematopoietic stem cells …

Attempted human allogeneic marrow transplants in the 1950s and 60s were largely
unsuccessful. In the past two decades the probability of success has improved steadily …

For more than 40 years, radiation or chemotherapy or both have been given in
myeloablative doses to cancer patients while their autologous hematopoietic cells were sto …

Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of
malignant and non-malignant diseases in children and adults. Initially developed as rescue …